Detalhe da pesquisa
1.
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
N Engl J Med
; 390(10): 875-888, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38446675
2.
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Lancet Oncol
; 25(2): 255-264, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142702
3.
Impact of a one-year supervised physical activity program on long-term cancer-related fatigue and mediating effects of the gut microbiota in metastatic testicular cancer patients: protocol of the prospective multicentre, randomized controlled phase-III STARTER trial.
BMC Cancer
; 24(1): 84, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225551
4.
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer.
Future Oncol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682560
5.
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Lancet
; 399(10336): 1695-1707, 2022 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405085
6.
Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes.
World J Urol
; 41(9): 2405-2411, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507528
7.
Extracranial germ cell tumours in children and adolescents: Results from the French TGM13 protocol.
Pediatr Blood Cancer
; 70(3): e30117, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36451268
8.
Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial.
Lancet Oncol
; 23(10): 1297-1307, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36063830
9.
Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy.
Br J Clin Pharmacol
; 88(7): 3182-3192, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029306
10.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(7): 931-945, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051178
11.
Could Aberrant Migration Explain Metachronous Germ Cell Tumors?
Cancer Invest
; 39(2): 195-201, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33017201
12.
Synchronous brain metastases as a poor prognosis factor in clear cell renal carcinoma: a strong argument for systematic brain screening.
J Neurooncol
; 153(1): 133-141, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837880
13.
Domestic use of pesticides during early periods of development and risk of testicular germ cell tumors in adulthood: a French nationwide case-control study.
Environ Health
; 20(1): 111, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706722
14.
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 21(1): 105-120, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753727
15.
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
Pharm Res
; 37(7): 147, 2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676789
16.
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
Lancet
; 391(10122): 748-757, 2018 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29268948
17.
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring.
Ther Drug Monit
; 41(1): 66-74, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30299429
18.
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 19(7): 975-986, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880291
19.
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial.
Lancet
; 390(10109): 2266-2277, 2017 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28916371
20.
Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial.
Lancet Oncol
; 18(11): 1532-1542, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29033099